Coagulation activation in sickle cell trait: An exploratory study

Chirag Amin, Soheir Adam, Micah J. Mooberry, Abdullah Kutlar, Ferdane Kutlar, Denise Esserman, Julia E. Brittain, Kenneth I. Ataga, Jen Yea Chang, Alisa S. Wolberg, Nigel S. Key

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Recent epidemiologic data suggest that sickle cell trait (HbAS; AS) is a risk factor for venous thromboembolism. We conducted an exploratory study of healthy subjects with AS under baseline conditions to determine whether a chronic basal hyperactivation of coagulation exists, and if so, what mechanism(s) contribute to this state. Eighteen healthy AS individuals were compared to 22 African-American controls with a normal haemoglobin profile (HbAA; AA) and 17 patients with sickle cell disease (HbSS; SS). Plasma thrombin-antithrombin complexes and D-dimer levels were elevated in AS relative to AA patients (P = 0·0385 and P = 0·017, respectively), and as expected, were much higher in SSversusAA (P < 0·0001 for both). Thrombin generation in platelet poor plasma was indistinguishable between AA and AS subjects, whereas a paradoxical decrease in endogenous thrombin potential was observed in SS (P ≤ 0·0001). Whole blood tissue factor was elevated in SS compared to AA (P = 0·005), but did not differ between AA and AS. Plasma microparticle tissue factor activity was non-significantly elevated in AS (P = 0·051), but was clearly elevated in SS patients (P = 0·004) when compared to AA controls. Further studies in larger cohorts of subjects with sickle cell trait are needed to confirm the results of this preliminary investigation.

Original languageEnglish (US)
Pages (from-to)638-646
Number of pages9
JournalBritish Journal of Haematology
Volume171
Issue number4
DOIs
StatePublished - Nov 2015

Fingerprint

Sickle Cell Trait
Thromboplastin
Thrombin
Venous Thromboembolism
Sickle Cell Anemia
African Americans
Healthy Volunteers
Hemoglobins
Blood Platelets

Keywords

  • Coagulation
  • Sickle
  • Thrombin
  • Tissue factor
  • Venous thrombosis

ASJC Scopus subject areas

  • Hematology

Cite this

Amin, C., Adam, S., Mooberry, M. J., Kutlar, A., Kutlar, F., Esserman, D., ... Key, N. S. (2015). Coagulation activation in sickle cell trait: An exploratory study. British Journal of Haematology, 171(4), 638-646. https://doi.org/10.1111/bjh.13641

Coagulation activation in sickle cell trait : An exploratory study. / Amin, Chirag; Adam, Soheir; Mooberry, Micah J.; Kutlar, Abdullah; Kutlar, Ferdane; Esserman, Denise; Brittain, Julia E.; Ataga, Kenneth I.; Chang, Jen Yea; Wolberg, Alisa S.; Key, Nigel S.

In: British Journal of Haematology, Vol. 171, No. 4, 11.2015, p. 638-646.

Research output: Contribution to journalArticle

Amin, C, Adam, S, Mooberry, MJ, Kutlar, A, Kutlar, F, Esserman, D, Brittain, JE, Ataga, KI, Chang, JY, Wolberg, AS & Key, NS 2015, 'Coagulation activation in sickle cell trait: An exploratory study', British Journal of Haematology, vol. 171, no. 4, pp. 638-646. https://doi.org/10.1111/bjh.13641
Amin, Chirag ; Adam, Soheir ; Mooberry, Micah J. ; Kutlar, Abdullah ; Kutlar, Ferdane ; Esserman, Denise ; Brittain, Julia E. ; Ataga, Kenneth I. ; Chang, Jen Yea ; Wolberg, Alisa S. ; Key, Nigel S. / Coagulation activation in sickle cell trait : An exploratory study. In: British Journal of Haematology. 2015 ; Vol. 171, No. 4. pp. 638-646.
@article{8d66be65ee3546bb83ce294a6a1db745,
title = "Coagulation activation in sickle cell trait: An exploratory study",
abstract = "Recent epidemiologic data suggest that sickle cell trait (HbAS; AS) is a risk factor for venous thromboembolism. We conducted an exploratory study of healthy subjects with AS under baseline conditions to determine whether a chronic basal hyperactivation of coagulation exists, and if so, what mechanism(s) contribute to this state. Eighteen healthy AS individuals were compared to 22 African-American controls with a normal haemoglobin profile (HbAA; AA) and 17 patients with sickle cell disease (HbSS; SS). Plasma thrombin-antithrombin complexes and D-dimer levels were elevated in AS relative to AA patients (P = 0·0385 and P = 0·017, respectively), and as expected, were much higher in SSversusAA (P < 0·0001 for both). Thrombin generation in platelet poor plasma was indistinguishable between AA and AS subjects, whereas a paradoxical decrease in endogenous thrombin potential was observed in SS (P ≤ 0·0001). Whole blood tissue factor was elevated in SS compared to AA (P = 0·005), but did not differ between AA and AS. Plasma microparticle tissue factor activity was non-significantly elevated in AS (P = 0·051), but was clearly elevated in SS patients (P = 0·004) when compared to AA controls. Further studies in larger cohorts of subjects with sickle cell trait are needed to confirm the results of this preliminary investigation.",
keywords = "Coagulation, Sickle, Thrombin, Tissue factor, Venous thrombosis",
author = "Chirag Amin and Soheir Adam and Mooberry, {Micah J.} and Abdullah Kutlar and Ferdane Kutlar and Denise Esserman and Brittain, {Julia E.} and Ataga, {Kenneth I.} and Chang, {Jen Yea} and Wolberg, {Alisa S.} and Key, {Nigel S.}",
year = "2015",
month = "11",
doi = "10.1111/bjh.13641",
language = "English (US)",
volume = "171",
pages = "638--646",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Coagulation activation in sickle cell trait

T2 - An exploratory study

AU - Amin, Chirag

AU - Adam, Soheir

AU - Mooberry, Micah J.

AU - Kutlar, Abdullah

AU - Kutlar, Ferdane

AU - Esserman, Denise

AU - Brittain, Julia E.

AU - Ataga, Kenneth I.

AU - Chang, Jen Yea

AU - Wolberg, Alisa S.

AU - Key, Nigel S.

PY - 2015/11

Y1 - 2015/11

N2 - Recent epidemiologic data suggest that sickle cell trait (HbAS; AS) is a risk factor for venous thromboembolism. We conducted an exploratory study of healthy subjects with AS under baseline conditions to determine whether a chronic basal hyperactivation of coagulation exists, and if so, what mechanism(s) contribute to this state. Eighteen healthy AS individuals were compared to 22 African-American controls with a normal haemoglobin profile (HbAA; AA) and 17 patients with sickle cell disease (HbSS; SS). Plasma thrombin-antithrombin complexes and D-dimer levels were elevated in AS relative to AA patients (P = 0·0385 and P = 0·017, respectively), and as expected, were much higher in SSversusAA (P < 0·0001 for both). Thrombin generation in platelet poor plasma was indistinguishable between AA and AS subjects, whereas a paradoxical decrease in endogenous thrombin potential was observed in SS (P ≤ 0·0001). Whole blood tissue factor was elevated in SS compared to AA (P = 0·005), but did not differ between AA and AS. Plasma microparticle tissue factor activity was non-significantly elevated in AS (P = 0·051), but was clearly elevated in SS patients (P = 0·004) when compared to AA controls. Further studies in larger cohorts of subjects with sickle cell trait are needed to confirm the results of this preliminary investigation.

AB - Recent epidemiologic data suggest that sickle cell trait (HbAS; AS) is a risk factor for venous thromboembolism. We conducted an exploratory study of healthy subjects with AS under baseline conditions to determine whether a chronic basal hyperactivation of coagulation exists, and if so, what mechanism(s) contribute to this state. Eighteen healthy AS individuals were compared to 22 African-American controls with a normal haemoglobin profile (HbAA; AA) and 17 patients with sickle cell disease (HbSS; SS). Plasma thrombin-antithrombin complexes and D-dimer levels were elevated in AS relative to AA patients (P = 0·0385 and P = 0·017, respectively), and as expected, were much higher in SSversusAA (P < 0·0001 for both). Thrombin generation in platelet poor plasma was indistinguishable between AA and AS subjects, whereas a paradoxical decrease in endogenous thrombin potential was observed in SS (P ≤ 0·0001). Whole blood tissue factor was elevated in SS compared to AA (P = 0·005), but did not differ between AA and AS. Plasma microparticle tissue factor activity was non-significantly elevated in AS (P = 0·051), but was clearly elevated in SS patients (P = 0·004) when compared to AA controls. Further studies in larger cohorts of subjects with sickle cell trait are needed to confirm the results of this preliminary investigation.

KW - Coagulation

KW - Sickle

KW - Thrombin

KW - Tissue factor

KW - Venous thrombosis

UR - http://www.scopus.com/inward/record.url?scp=84945441807&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84945441807&partnerID=8YFLogxK

U2 - 10.1111/bjh.13641

DO - 10.1111/bjh.13641

M3 - Article

C2 - 26511074

AN - SCOPUS:84945441807

VL - 171

SP - 638

EP - 646

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

IS - 4

ER -